Sign in

Colorectal cancer: trials that stopped early

Trials on Colorectal cancer that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

254 stopped trials give a reason in the registry, latest registry update first. 4 more give no reason and are not listed.

  1. Terminated

    A Phase 1 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway

    Reason given in the registry

    “business objectives have changed”

    Quoted unchanged from ClinicalTrials.gov; record updated 19 Feb 2026.

    Ended
    Feb 2026
    Phase
    Phase 1
    Run by
    Mirati Therapeutics Inc.
    Registry record
    NCT05578092
  2. Withdrawn

    Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

    Reason given in the registry

    “The trial is closing due to findings from a related study, prompting the sponsor to discontinue development and end this study.”

    Quoted unchanged from ClinicalTrials.gov; record updated 19 Feb 2026.

    Ended
    Aug 2025
    Phase
    Phase 2
    Run by
    National Cancer Institute (NCI)
    Registry record
    NCT06603818
  3. Terminated

    Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

    Reason given in the registry

    “\< 75% participation”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Feb 2026.

    Ended
    Dec 2025
    Phase
    Phase 2
    Run by
    M.D. Anderson Cancer Center
    Registry record
    NCT02738606
  4. Withdrawn

    Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs

    Reason given in the registry

    “Lack of funding”

    Quoted unchanged from ClinicalTrials.gov; record updated 11 Feb 2026.

    Ended
    Oct 2025
    Run by
    Karolinska Institutet
    Registry record
    NCT05512260
  5. Withdrawn

    Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

    Reason given in the registry

    “Principal Investigator has left Inova”

    Quoted unchanged from ClinicalTrials.gov; record updated 11 Feb 2026.

    Ended
    Sept 2025
    Phase
    Phase 2
    Run by
    Inova Health Care Services
    Registry record
    NCT06501989
  6. Withdrawn

    A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer

    Reason given in the registry

    “Sponsor's decision”

    Quoted unchanged from ClinicalTrials.gov; record updated 9 Feb 2026.

    Phase
    Phase 2
    Run by
    Hoffmann-La Roche
    Registry record
    NCT07323576
  7. Withdrawn

    Living Donor Liver Transplantation for CRC Liver Metastases

    Reason given in the registry

    “Slow accrual”

    Quoted unchanged from ClinicalTrials.gov; record updated 6 Feb 2026.

    Run by
    University of Wisconsin, Madison
    Registry record
    NCT05175092
  8. Terminated

    A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys

    Reason given in the registry

    “Slow study accrual. Study sponsor decided to terminate the study in consultation with the DSMB.”

    Quoted unchanged from ClinicalTrials.gov; record updated 5 Feb 2026.

    Ended
    Sept 2025
    Run by
    AHS Cancer Control Alberta
    Registry record
    NCT04990895
  9. Suspended

    Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients

    Reason given in the registry

    “due to earlier termination of the agreement between the Sponsor and Central Laboratory for screening test. Enrollment will reopen as soon as a new laboratory is identified.”

    Quoted unchanged from ClinicalTrials.gov; record updated 3 Feb 2026.

    Phase
    Phase 2
    Run by
    Gruppo Oncologico del Nord-Ovest
    Registry record
    NCT05062889
  10. Terminated

    RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

    Reason given in the registry

    “Business reasons.”

    Quoted unchanged from ClinicalTrials.gov; record updated 2 Feb 2026.

    Ended
    Aug 2025
    Phase
    Phase 2
    Run by
    Replimune, Inc.
    Registry record
    NCT05733611
  11. Terminated

    Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

    Reason given in the registry

    “The platform used for detecting ctDNA was not sensitive enough.”

    Quoted unchanged from ClinicalTrials.gov; record updated 29 Jan 2026.

    Ended
    Jul 2024
    Run by
    Oslo University Hospital
    Registry record
    NCT06290856
  12. Terminated

    A Study of PHN-010 in Patients With Advanced Solid Tumors

    Reason given in the registry

    “The study was terminated by Sponsor for strategic reasons.”

    Quoted unchanged from ClinicalTrials.gov; record updated 29 Jan 2026.

    Ended
    Sept 2025
    Phase
    Phase 1
    Run by
    Pheon Therapeutics
    Registry record
    NCT06457997
  13. Terminated

    Evaluation of the Efficacy of Two Guidance Techniques (Standard Injected CT vs Porto-scanner With Angio-CT) for Thermoablation Treatment of Colorectal Cancer Liver Metastases

    Reason given in the registry

    “* Not enough inclusions * Montpellier is not included (0 inclusions) * Of the 7 patients included, there were recurrences in both groups, raising questions about the relevance of the study. * One serious complication in one group was reported.”

    Quoted unchanged from ClinicalTrials.gov; record updated 23 Jan 2026.

    Ended
    Oct 2025
    Run by
    Centre Hospitalier Universitaire de Nīmes
    Registry record
    NCT05665322
  14. Terminated

    Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer

    Reason given in the registry

    “Terminated per directive from Bayer due to funding.”

    Quoted unchanged from ClinicalTrials.gov; record updated 20 Jan 2026.

    Ended
    Nov 2025
    Phase
    Phase 2
    Run by
    Anwaar Saeed
    Registry record
    NCT06006923
  15. Terminated

    Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients

    Reason given in the registry

    “Medical devices (QuiremScout/QuiremSpheres) no longer available due to discontinuation of production by the manufacturer”

    Quoted unchanged from ClinicalTrials.gov; record updated 5 Jan 2026.

    Ended
    Dec 2025
    Phase
    Phase 2
    Run by
    Gruppo Oncologico del Nord-Ovest
    Registry record
    NCT06332079
  16. Terminated

    Glutamine PET Imaging Colorectal Cancer

    Reason given in the registry

    “\<75% participation”

    Quoted unchanged from ClinicalTrials.gov; record updated 2 Jan 2026.

    Ended
    Dec 2025
    Phase
    Phase 1
    Run by
    M.D. Anderson Cancer Center
    Registry record
    NCT03275974
  17. Terminated

    Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

    Reason given in the registry

    “Sponsor decision”

    Quoted unchanged from ClinicalTrials.gov; record updated 31 Dec 2025.

    Ended
    Sept 2025
    Phase
    Phase 2
    Run by
    Chloe Atreya, MD, PhD
    Registry record
    NCT03844750
  18. Withdrawn

    STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

    Reason given in the registry

    “no resource”

    Quoted unchanged from ClinicalTrials.gov; record updated 24 Dec 2025.

    Phase
    Phase 1
    Run by
    City of Hope Medical Center
    Registry record
    NCT06626256
  19. Terminated

    KZR-261 in Subjects With Advanced Solid Malignancies

    Reason given in the registry

    “Sponsor decision.”

    Quoted unchanged from ClinicalTrials.gov; record updated 19 Dec 2025.

    Ended
    Jan 2025
    Phase
    Phase 1
    Run by
    Kezar Life Sciences, Inc.
    Registry record
    NCT05047536
  20. Suspended

    Real-Time Feedback (RTFB) to Improve Colonoscopy

    Reason given in the registry

    “we are on hold and may restart depending on a manual followed by automated assessment of existing files”

    Quoted unchanged from ClinicalTrials.gov; record updated 9 Dec 2025.

    Run by
    University of Minnesota
    Registry record
    NCT05241210
  21. Suspended

    Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

    Reason given in the registry

    “no slots available”

    Quoted unchanged from ClinicalTrials.gov; record updated 4 Dec 2025.

    Phase
    Phase 2
    Run by
    Rutgers, The State University of New Jersey
    Registry record
    NCT05358704
  22. Terminated

    A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

    Reason given in the registry

    “The trial was stopped early on the initiative of the sponsor on the basis of a change in the research and development strategy without safety concerns”

    Quoted unchanged from ClinicalTrials.gov; record updated 3 Dec 2025.

    Ended
    Jan 2024
    Phase
    Phase 1
    Run by
    Shanghai Junshi Bioscience Co., Ltd.
    Registry record
    NCT05427396
  23. Suspended

    A Community-Based Educational Intervention to Improve Colorectal Cancer Screening

    Reason given in the registry

    “staffing”

    Quoted unchanged from ClinicalTrials.gov; record updated 28 Nov 2025.

    Ended
    Sept 2026
    Run by
    Thomas Jefferson University
    Registry record
    NCT04392050
  24. Terminated

    Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

    Reason given in the registry

    “Sponsor decision”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Nov 2025.

    Ended
    Aug 2025
    Phase
    Phase 1
    Run by
    Bolt Biotherapeutics, Inc.
    Registry record
    NCT06052852
  25. Terminated

    A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

    Reason given in the registry

    “Due to lack of expected efficacy shown at the time of the interim analysis”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Nov 2025.

    Ended
    Nov 2024
    Phase
    Phase 2
    Run by
    SOTIO Biotech AG
    Registry record
    NCT05256381
  26. Terminated

    Informed Choice - Compass

    Reason given in the registry

    “Business decision to terminate the study early. Primary endpoint will not be assessed.”

    Quoted unchanged from ClinicalTrials.gov; record updated 10 Nov 2025.

    Ended
    Jan 2025
    Run by
    Exact Sciences Corporation
    Registry record
    NCT05246839
  27. Terminated

    Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

    Reason given in the registry

    “Recruitment challenges”

    Quoted unchanged from ClinicalTrials.gov; record updated 29 Oct 2025.

    Ended
    Aug 2024
    Phase
    Phase 2
    Run by
    Tempus AI
    Registry record
    NCT05169437
  28. Withdrawn

    Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer

    Reason given in the registry

    “Redesign of protocol for primary end-point of overall survival”

    Quoted unchanged from ClinicalTrials.gov; record updated 21 Oct 2025.

    Phase
    Phase 2
    Run by
    Mirror Biologics, Inc.
    Registry record
    NCT06557278
  29. Terminated

    A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

    Reason given in the registry

    “Sponsor's strategic business decision”

    Quoted unchanged from ClinicalTrials.gov; record updated 15 Oct 2025.

    Ended
    Aug 2025
    Phase
    Phase 1
    Run by
    Actym Therapeutics, Inc.
    Registry record
    NCT06336148
  30. Terminated

    YASU Research Registry: For Young Adults With Cancer

    Reason given in the registry

    “Sponsoring organization no longer desired to recruit/maintain registry”

    Quoted unchanged from ClinicalTrials.gov; record updated 14 Oct 2025.

    Ended
    Sept 2025
    Run by
    Young Adult Survivors United
    Registry record
    NCT06275854

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.